Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Kidney Dis. 2014 Oct 14;65(3):394–402. doi: 10.1053/j.ajkd.2014.07.026

Figure 2.

Figure 2

Cumulative incidence of end-stage renal disease and death prior to end-stage renal disease from eGFR 30 ml/min/1.73 m2, eGFR 15 ml/min/1.73 m2, and 5%, 10%, and 20% 1-year risk of end-stage renal disease†

† Curves reflect cumulative incidence of ESRD and pre-ESRD mortality, where each outcome is treating as a competing event for the other. Confidence intervals were calculated by a boot-strap method using 10,000 repetitions. Models were adjusted to eGFR 30 and 15 ml/min/1.73 m2 in the eGFR threshold analyses and 5%, 10%, and 20% 1-year ESRD risk in the kidney failure risk threshold analyses. Solid circles represent incidence at 1 year.